Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C

Journal of Hepatology

Volumn 46, Issue 4, 2007, Pages 605-612

  Vidali, Matteo ^a   Occhino, Giuseppa ^a   Ivaldi, Alessandra ^a   Serino, Roberto ^a   Moia, Stefania ^a   Alchera, Elisa ^a   Carini, Rita ^a   Rigamonti, Cristina ^a,b   Sartori, Massimo ^c   Albano, Emanuele ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

Auto immunity; Cytochrome P450; Hepatitis C

Indexed keywords

AUTOANTIBODY; CYTOCHROME P450;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; GENOTYPE; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; LIVER BIOPSY; MALE; PRIORITY JOURNAL; SOLID;

ADULT; AGED; ALCOHOL DRINKING; ANIMALS; AUTOANTIBODIES; CELL MEMBRANE; CYTOCHROME P-450 CYP2E1; FEMALE; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMMUNOGLOBULIN G; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TISSUE DISTRIBUTION;

EID: 33947176201     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.11.009     Document Type: Article

References (38)

1. Strassburg C.P., Vogel A., and Manns M.P. Autoimmunity and hepatitis C. Autoimmun Rev 2 (2003) 322-331
2. Ramos-Casals M., Trejo O., Garcia-Carrasco M., Cervera R., De La Red G., Gil V., et al. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma. J Rheumatol 31 (2004) 495-499
3. Clifford B.D., Donahue D., Smith L., Cable E., Luttig B., Manns M., et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21 (1995) 613-619
4. Cassani F., Cataleta M., Valentini P., Muratori P., Giostra F., Francesconi R., et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 26 (1997) 561-566
5. Lenzi M., Manotti P., Muratori L., Cataleta M., Ballardini G., Cassani F., et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut 36 (1995) 749-754
6. Strassburg C.P., and Manns M.P. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis 22 (2002) 339-352
7. Muratori L., Parola M., Ripalti A., Robino G., Muratori P., Bellomo G., et al. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 46 (2000) 553-561
8. Lapierre P., Djilali-Saiah I., Vitozzi S., and Alvarez F. A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens. Hepatology 39 (2004) 1066-1074
9. Manns M.P., Griffin K.J., Sullivan K.F., and Johnson E.F. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monoxygenase. J Clin Invest 88 (1991) 1370-1378
10. Yamamoto A.M., Cresteil D., Homberg J.C., and Alvarez F. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and negative sera. Gastroenterology 104 (1993) 1762-1767
11. 193-212: a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 170 (2003) 1481-1489
12. Dalekos G.N., Obermayer-Straub P., Bartels M., Maeda T., Kayser A., Braun S., et al. Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection. J Hepatol 39 (2003) 800-806
13. Miyakawa H., Kitazawa E., Kikuchi K., Fujikawa H., Kawaguchi N., Abe K., et al. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C. Autoimmunity 33 (2001) 23-32
14. Safdar K., and Schiff E.R. Alcohol and hepatitis C. Semin Liver Dis 24 (2004) 305-315
15. Westin J., Lagging L.M., Spak F., Aires N., Svensson E., Lindh M., et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Vir Hepatol 9 (2002) 235-241
16. Rigamonti C., Mottaran E., Reale E., Rolla R., Cipriani V., Capelli F., et al. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 38 (2003) 42-49
17. Vidali M., Stewart S.F., Rolla R., Daly A.K., Chen Y., Mottaran E., et al. Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatology 37 (2003) 277-285
18. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Guadat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
19. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes. Evidence of its hemoprotein nature. J Biol Chem 239 (1964) 2370-2378
20. Clot P., Parola M., Bellomo G., Dianzani U., Carini R., Tabone M., et al. Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology 113 (1997) 265-276
21. Loeper J., Descatoire V., Maurice M., Beaune P., Belghiti J., Houssin D., et al. Cytochrome P450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 104 (1993) 203-216
22. Bourdi M., Chen W., Peter R.M., Martin J.L., Buters J.T.M., Nelson S.D., et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 9 (1996) 1159-1166
23. Hoet P., Graf M.L., Bourdi M., Pohl M.L., Duray P.H., Chen W., et al. Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluoro carbons. Lancet 350 (1997) 556-559
24. Njoko D.B., Mellerson J.L., Talor M.V., Kerr D.R., Faraday N.R., Outshoor I., et al. Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in the pathogenesis of idiosyncratic drug-induced hepatitis. Clin Vac Immunol 13 (2006) 258-265
25. Eliasson E., and Kenna J.G. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 50 (1996) 573-582
26. Vidali M., Hidestrand M., Eliasson E., Mottaran E., Reale E., Rolla R., et al. Use of molecular simulation for mapping conformational CYP2E1 epitopes. J Biol Chem 279 (2004) 50949-50955
27. Marceau G., Lapierre P., Beland K., Soudeyns H., and Alvarez F. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?. Hepatology 42 (2005) 675-682
28. Wu D.F., and Cederbaum A.I. Presence of functionally active cytochrome P-450IIE1 in plasma membrane of rat hepatocytes. Hepatol 15 (1992) 515-524
29. Neve E.P., Eliasson E., Pronzato M.A., Albano E., Marinari U., and Ingelman-Sundberg M. Enzyme-specific transport of rat liver cytochrome P450 to the Golgi apparatus. Arch Biochem Biophys 333 (1996) 459-465
30. Serfaty L., Poujol-Robert A., Carbonell N., Chazouilleres O., Poupon R.E., and Poupon R. Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C. Am J Gastroenterol 97 (2002) 1807-1812
31. Lohr H.F., Schlaak J.F., Lohse A.W., Bocher W.O., Arenz M., Gerken G., et al. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology 24 (1996) 1416-1421
32. Arenz M., Pingel S., Schirmacher P., Meyer zum Buschenfelde K.H., and Lohr H.F. T cell receptor Vbeta chain restriction and preferred CDR3 motifs of liver-kidney microsomal antigen (LKM-1)-reactive T cells from autoimmune hepatitis patients. Liver 21 (2001) 18-25
33. Liangpunsakul S., Kolwankar D., Pinto A., Gorski C.J., Hall S.D., and Chalasani N. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics. Hepatology 41 (2005) 1144-1150
34. Dupont I., Lucas D., Clot P., Ménez C., and Albano E. Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics. J Hepatology 28 (1998) 64-571
35. Oneta C.M., Lieber C.S., Li J., Ruttimann S., Schmid B., Lattmann J., et al. Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36 (2002) 47-52
36. Lonardo A., Adinolfi L.E., Loria P., Carulli N., Ruggiero G., and Day C.P. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 126 (2004) 586-597
37. Chalasani N., Gorski J.C., Asghar M.S., Asghar A., Foresman B., Hall S.D., et al. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 37 (2003) 544-550
38. Emery M.G., Fisher J.M., Chien J.Y., Kharasch E.D., Dellinger E.P., Kowdley K.V., et al. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology 38 (2003) 428-435